Platelet-suppressive therapy in cardiovascular disease.
D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000097:blood; D012306:Risk; D013928:Thromboxane A2 / Q000097:blood
D005343:Fibrinolytic Agents; D011453:Prostaglandins; D013928:Thromboxane A2